N-(5-acetyl-1,3-thiazol-2-yl)-2,2-dimethylpropanamide, 95.0%, 250mg

4-((4-Ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)aniline, 98.0%, 1g

5-Bromo-4-isopropylthiazole, 95+%, 100mg

3-Fluoro-4,5-dihydroxybenzaldehyde, 97%, 250mg

8-NITROQUINOLINE-4-CARBOXYLIC ACID, 95.0%, 100mg

5-benzyl-4H-1,2,4-triazole-3-carboxylic acid, 95%, 1g

1-((3AR,4R,6R,6aR)-6-(hydroxymethyl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)pyrimidine-2,4(1H,3H)-dione, 98.0%, 10g

Gly-b-Ala-NH2�HCl, 98.0%, 1g

3-Methoxycarbonyl-5-nitrophenylboronic acid, 98.0%, 100g

N-METHOXY-N-METHYL-2-(2-NITROPHENYL)ACETAMIDE, 95.0%, 100mg

Solución de cloruro de deuterio al 38% en D2O, 99,5% átomo D, 10 ml, envase de vidrio

monoclonal de ratón anti-queratina K6, KA12, 0,2 ml

2-(4-CHLOROBENZO[D]THIAZOL-2-YL)ACETIC ACID, 95.0%, 250mg